GARDASIL
MERCK CANADA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GARDASIL discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GARDASIL 20MCG 40MCG 40MCG 20MCG has been permanently discontinued (last updated August 23, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GARDASIL not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02283190
Strength
20MCG 40MCG 40MCG 20MCG
Dosage Form
SUSPENSION
Route
INTRAMUSCULAR
Active Ingredient
RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Compare with another product →
Shortage History
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
10MG · DIN 02483513
20MG · DIN 02483548
15MG · DIN 02483521
100MG · DIN 02451816
70MG · DIN 02244266
50MG · DIN 02244265
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00688622
0.05% · DIN 00862975